These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16430799)

  • 1. Aprotinin and renal function at cardiac surgery.
    McBride WT; Allen JS; Armstrong MA
    Eur J Anaesthesiol; 2006 Mar; 23(3):261-2; author reply 262. PubMed ID: 16430799
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
    Dietrich W; Busley R; Boulesteix AL
    Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
    Hill SE
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

  • 7. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 8. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
    McEvoy MD; Reeves ST; Reves JG; Spinale FG
    Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin combined with nitric oxide and prostaglandin E1 protects the canine kidney from cardiopulmonary bypass-induced injury.
    Du L; Zhou J; Tang J; An Q; Lin K; Wu X; Tao K; Liu J
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):98-103. PubMed ID: 20188582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracardiac thrombosis and acute right ventricular failure following complex reoperative cardiac surgery with aprotinin and deep hypothermic circulatory arrest.
    Stone ME; Silverman SH; Nomoto K
    Semin Cardiothorac Vasc Anesth; 2007 Sep; 11(3):177-84. PubMed ID: 17711970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin and renal dysfunction after pediatric cardiac surgery.
    Székely A; Sápi E; Breuer T; Kertai MD; Bodor G; Vargha P; Szatmári A
    Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin--still courting controversy.
    Hausenloy DJ; Pagano D; Keogh B
    Lancet; 2008 Feb; 371(9611):449-50. PubMed ID: 18262023
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
    Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suction, salvage, sutures, and potions: blood management post-aprotinin.
    Baker RA
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):122-6. PubMed ID: 19617252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass.
    Boehm J; Grammer JB; Lehnert F; Dietrich W; Wagenpfeil S; Wildhirt SM; Wottke M; Braun S; Lange R; Bauernschmitt R
    Anesthesiology; 2007 Apr; 106(4):681-6. PubMed ID: 17413905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit.
    D'Errico CC; Munro HM; Bove EL
    J Cardiothorac Vasc Anesth; 1999 Dec; 13(6):782-4. PubMed ID: 10622665
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation in cardiac surgery.
    Royston D
    Adv Card Surg; 1996; 8():19-45. PubMed ID: 9111648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.